Page last updated: 2024-09-02

6-methyl-1,3,8-trichlorodibenzofuran and 9,10-dimethyl-1,2-benzanthracene

6-methyl-1,3,8-trichlorodibenzofuran has been researched along with 9,10-dimethyl-1,2-benzanthracene in 1 studies

Compound Research Comparison

Studies
(6-methyl-1,3,8-trichlorodibenzofuran)
Trials
(6-methyl-1,3,8-trichlorodibenzofuran)
Recent Studies (post-2010)
(6-methyl-1,3,8-trichlorodibenzofuran)
Studies
(9,10-dimethyl-1,2-benzanthracene)
Trials
(9,10-dimethyl-1,2-benzanthracene)
Recent Studies (post-2010) (9,10-dimethyl-1,2-benzanthracene)
25036,01010772

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McDougal, A; Safe, S; Wilson, C1

Other Studies

1 other study(ies) available for 6-methyl-1,3,8-trichlorodibenzofuran and 9,10-dimethyl-1,2-benzanthracene

ArticleYear
Inhibition of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor growth by aryl hydrocarbon receptor agonists.
    Cancer letters, 1997, Nov-25, Volume: 120, Issue:1

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Aryl Hydrocarbon Receptor Nuclear Translocator; Benzofurans; Cytochrome P-450 CYP1A1; DNA-Binding Proteins; Estrogen Antagonists; Female; Gene Expression Regulation, Neoplastic; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Receptors, Aryl Hydrocarbon; Transcription Factors

1997
chemdatabank.com